2009 related articles for article (PubMed ID: 10733371)
1. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Ridker PM; Hennekens CH; Buring JE; Rifai N
N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
[TBL] [Abstract][Full Text] [Related]
2. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
Ridker PM; Rifai N; Rose L; Buring JE; Cook NR
N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory markers and the risk of coronary heart disease in men and women.
Pai JK; Pischon T; Ma J; Manson JE; Hankinson SE; Joshipura K; Curhan GC; Rifai N; Cannuscio CC; Stampfer MJ; Rimm EB
N Engl J Med; 2004 Dec; 351(25):2599-610. PubMed ID: 15602020
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
Danesh J; Wheeler JG; Hirschfield GM; Eda S; Eiriksdottir G; Rumley A; Lowe GD; Pepys MB; Gudnason V
N Engl J Med; 2004 Apr; 350(14):1387-97. PubMed ID: 15070788
[TBL] [Abstract][Full Text] [Related]
6. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
8. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
9. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
Albert MA; Glynn RJ; Buring J; Ridker PM
Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
[TBL] [Abstract][Full Text] [Related]
10. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
[TBL] [Abstract][Full Text] [Related]
11. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
[TBL] [Abstract][Full Text] [Related]
12. Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X.
Leu HB; Lin CP; Lin WT; Wu TC; Lin SJ; Chen JW
Free Radic Biol Med; 2006 Mar; 40(6):983-91. PubMed ID: 16540394
[TBL] [Abstract][Full Text] [Related]
13. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
15. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
Piché ME; Lemieux S; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J
Am J Cardiol; 2005 Jul; 96(1):92-7. PubMed ID: 15979442
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein: a new risk assessment tool for cardiovascular disease.
Clearfield MB
J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
[TBL] [Abstract][Full Text] [Related]
18. The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study.
Chrysohoou C; Pitsavos C; Skoumas J; Masoura C; Katinioti A; Panagiotakos D; Stefanadis C
Int J Cardiol; 2007 Oct; 122(1):29-33. PubMed ID: 17188378
[TBL] [Abstract][Full Text] [Related]
19. Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification.
Grewal J; Chan S; Frohlich J; Mancini GB
Clin Invest Med; 2003 Aug; 26(4):158-65. PubMed ID: 12934819
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
